According to the Baveno VII consortium, there is an indication for short-term albumin administration in patients with SBP, acute kidney injury (AKI), large-volume paracentesis (>5 L), and, in combination with terlipressin, in the treatment of hepatorenal syndrome (HRS) [18]. This evidence concerns the gene ALB and hepatorenal syndrome.